Iovance Biotherapeutics IOVA
NASDAQ IOVA
$14.09 -0.05 (-0.35%)
At close: Oct 23, 2026 · 4:00 PM EDT

Iovance Biotherapeutics (IOVA) Gains from Sales and Divestitures (2018 - 2026)

Updated

Iovance Biotherapeutics' Gains from Sales and Divestitures was -$642,000 in Q2 2026.

Analysis

Iovance Biotherapeutics (IOVA) Gains from Sales and Divestitures (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, Iovance Biotherapeutics' Gains from Sales and Divestitures was -$670,000 through Jun 30, 2026; for FY2025, it was -$44,000.

  • In earlier years, Gains from Sales and Divestitures was -$7.36 million in FY2024 and -$397,000 in FY2022.
  • The Q2 2026 figure marks the lowest quarterly Gains from Sales and Divestitures since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Iovance Biotherapeutics 6.34 Bn 5.13 Bn 55.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -642,000.00
Mar 31, 2026 -28,000.00
Mar 31, 2025 -44,000.00
Dec 31, 2024 -7.36 Mn
Mar 31, 2018 -9,000.00
API Access

Iovance Biotherapeutics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=IOVA&period=max&api_key=YOUR_API_KEY